A division of Pfizer Inc., this company focuses on pharmaceutical development and manufacturing, with no active involvement in rare diseases or orphan drug designations.
0
Orphan Designations
10
FDA Approvals
Latest: LYRICA (2004)
0
Active Trials
0
Rare Diseases
0
News (30d)
Quiet
Parke-Davis Div of Pfizer Inc is a company with 0 orphan drug designations across 0 rare diseases, including 10 FDA-approved therapies.
Disease-by-disease pipeline progression from orphan designation through clinical trials to FDA approval.
Source: FDA Orphan Drug Designations, ClinicalTrials.gov, Drugs@FDA
No pipeline data available yet.